Contact

Shane Gleghorn

Associé

Read More
Contact

Shane Gleghorn

Associé

Read More

4 novembre 2021

Recognised in The Times' Best Law Firms 2022 list

For the fourth consecutive year since the awards began, we have been included in The Times' list of Best Law Firms. We have been recommended across four categories: inheritance and succession, intellectual property, tax, and technology, media and telecoms.

Firms are recognised in the report as a result of direct market feedback with solicitors and barristers across England and Wales asked to recommend the best law firms in any of 26 categories covering business, public and private client fields. 

We were especially commended for the multimillion-dollar fundraising projects we worked on this year for life sciences clients Centessa Pharmaceuticals, Ventyx Biosciences and Apollo Therapeutics, and for advising pioneer biotech company Nuclera on its acquisition of E Ink's digital microfluidics.

Specific reference was also made to the opening of our new office in Dublin in September. 

Managing Partner Shane Gleghorn said:"Our inclusion in The Times list acknowledges our in-depth sector expertise and market-leading client experience, particularly in relation to the life sciences, technology and private wealth sectors. This deep sector knowledge, the considerable talent across our firm and a consistent commitment to excellence enables us to provide the best possible service to our clients."

Read the full The Times Best Law Firms list

 

 

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Responsabilité du fait des produits et de la sécurité des produits

Katie Chandler recognised in The Lawyer's Hot 100 2024

29 janvier 2024

par Shane Gleghorn et Katie Chandler

Cliquer ici pour en savoir plus
Royaume-Uni

Alexandre Silberman’s portrait 'Diena' wins the Taylor Wessing Photo Portrait Prize 2023

9 novembre 2023

par Shane Gleghorn

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Further recognition for our market-leading work in the life sciences sector

21 septembre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus